Dominick A. Leone, MPH, MS - Boston University School of Public Health - Pre-Doctoral Candidate

Dominick A. Leone

MPH, MS

Boston University School of Public Health

Pre-Doctoral Candidate

Boston, Massachusetts | United States

Main Specialties: Epidemiology, Infectious Disease, Medical Genetics, Molecular Genetic Pathology, Nephrology, Public Health

Additional Specialties: Precision Approach to Population Health: Genomic and Infectious Disease Epidemiology

ORCID logohttps://orcid.org/0000-0002-6401-2292

Dominick A. Leone, MPH, MS - Boston University School of Public Health - Pre-Doctoral Candidate

Dominick A. Leone

MPH, MS
Introduction

Primary Affiliation: Boston University School of Public Health - Boston, Massachusetts , United States

Specialties:

Additional Specialties:

Research Interests:

Metrics

13

Publications

1093

Profile Views

136

Reads

21

PubMed Central Citations

Education
Sep 2011 - May 2013
Boston University School of Public Health
Master of Public Health
Aug 2002 - Apr 2003
Georgetown University
Master of Science
May 2002
University of Central Florida
Bachelors of Science
Experience
Sep 2018
Framingham Heart Study
Graduate Research Assistant
Aug 2017
Channing Division of Network Medicine
Programmer Analyst
Jul 2015 - Jul 2015
Ragon Institute
Clinical Research Coordinator
Top co-authors
Meera Mahalingam
Meera Mahalingam

Boston University School of Medicine

11
Shi Yang
Shi Yang

Renji Hospital

10
Brendon Mitchell
Brendon Mitchell

University of Florida College of Medicine

6
April Deng
April Deng

University of Maryland

5
Noah Frydenlund
Noah Frydenlund

Boston University School of Medicine

5
Rajendra Singh
Rajendra Singh

Institute of Tissue Regeneration Engineering (ITREN)

5
Asok Biswas
Asok Biswas

Western General Hospital

4
Ron Yaar
Ron Yaar

Boston University School of Medicine

4
Mai P Hoang
Mai P Hoang

Massachusetts General Hospital

3

Publications

13Publications

136Reads

21PubMed Central Citations

Concordance of somatic mutation profiles [BRAF, NRAS and TERT] and tumoral PD-L1 in matched primary cutaneous and metastatic melanoma samples.

Hum Pathol 2018 Aug 15. Epub 2018 Aug 15.

Dermatopathology Section, VA Integrated Systems Network (VISN1), Department of Pathology and Laboratory Medicine, West Roxbury, MA 02132. Electronic address:

View Article
August 2018
7 Reads
2.77 Impact Factor

Tumoral PD-L1 expression in desmoplastic melanoma is associated with depth of invasion, tumor-infiltrating CD8 cytotoxic lymphocytes and the mixed cytomorphological variant.

Mod Pathol 2017 03 13;30(3):357-369. Epub 2017 Jan 13.

Dermatopathology Section, Department of Pathology and Laboratory Medicine (113), VA Integrated Service Networks (VISN1), West Roxbury, MA, USA.

View Article
March 2017
35 Reads
7 PubMed Central Citations(source)
6.19 Impact Factor

BRAF and epithelial-mesenchymal transition in papillary thyroid carcinoma - challenging the roles of Snail and E-Cadherin?

Am J Transl Res 2016 15;8(11):5076-5086. Epub 2016 Nov 15.

ENT Specialists, Inc. 825 Washington St # 310, Norwood, MA 02062, UK.

View Article
November 2016
3 Reads
3.23 Impact Factor

Frequency of telomerase reverse transcripter promoter mutations in desmoplastic melanoma subtypes: analyses of 76 cases.

Melanoma Res 2016 08;26(4):361-6

aDepartment of Pathology, Boston University of Medicine bBoston University School of Public Health and Ragon Institute of MGH, MIT and Harvard cDepartment of Pathology, Massachusetts General Hospital, Boston dMiraca Life Sciences, Newton Upper Falls eDepartment of Pathology, University of Massachusetts Medical School, Worcester fDermatopathology Section, VA Integrated Systems Network (VISN1), Department of Pathology and Laboratory Medicine, West Roxbury, Massachusetts gCarver College of Medicine, University of Iowa, Iowa City, Iowa hDepartment of Pathology and Dermatology, Icahn School of Medicine Mount Sinai, New York, New York iAurora Diagnostics GPA Laboratories, Greensboro, North Carolina, USA jDepartment of Pathology, Western General Hospital, Edinburgh, Scotland, UK.

View Article
August 2016
7 Reads
2 PubMed Central Citations(source)
2.28 Impact Factor

Neurofibromin protein loss in desmoplastic melanoma subtypes: implicating NF1 allelic loss as a distinct genetic driver?

Hum Pathol 2016 07 9;53:82-90. Epub 2016 Mar 9.

Dermatopathology Section, Department of Pathology and Laboratory Medicine, VA Consolidated Laboratories, West Roxbury, MA 02132. Electronic address:

View Article
July 2016
8 Reads
1 PubMed Central Citation(source)
2.77 Impact Factor

BRAF and epithelial-mesenchymal transition in primary cutaneous melanoma: a role for Snail and E-cadherin?

Hum Pathol 2016 06 1;52:19-27. Epub 2016 Feb 1.

Dermatopathology Section, VA Consolidated Laboratories, Department of Pathology and Laboratory Medicine (113), West Roxbury, MA 02132. Electronic address:

View Article
June 2016
6 Reads
1 PubMed Central Citation(source)
2.77 Impact Factor

Perineural invasion in cutaneous squamous cell carcinoma: role of immunohistochemistry, anatomical site, and the high-affinity nerve growth factor receptor TrkA.

Hum Pathol 2015 Aug 22;46(8):1209-16. Epub 2015 May 22.

Department of Pathology and Laboratory Medicine (113), VA Medical Center, 1400 VFW PKWY, MA 02132 USA, USA. Electronic address:

View Article
August 2015
9 Reads
2 PubMed Central Citations(source)
2.77 Impact Factor

Neurotrophin receptors and perineural invasion in desmoplastic melanoma.

J Am Acad Dermatol 2015 May 7;72(5):851-8. Epub 2015 Mar 7.

Dermatopathology, Section, Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts. Electronic address:

View Article
May 2015
8 Reads
4.45 Impact Factor

Microvessel density, lymphovascular density, and lymphovascular invasion in primary cutaneous melanoma-correlation with histopathologic prognosticators and BRAF status.

Hum Pathol 2015 Feb 26;46(2):304-12. Epub 2014 Nov 26.

Dermatopathology Section, Department of Dermatology, Boston University School of Medicine, Boston, MA 02118. Electronic address:

View Article
February 2015
4 Reads
2 PubMed Central Citations(source)
2.77 Impact Factor

Correlation of chemokine receptor CXCR4 mRNA in primary cutaneous melanoma with established histopathologic prognosticators and the BRAF status.

Melanoma Res 2014 Dec;24(6):621-5

aDivision of Graduate Medical Sciences bSchool of Public Health cBoston University School of Medicine dDepartment of Pathology eDepartment of Dermatology, Dermatopathology Section, Boston University School of Medicine, Boston, Massachusetts, USA.

View Article
December 2014
13 Reads
2.28 Impact Factor

Protein expression of the chemokine receptor CXCR4 and its ligand CXCL12 in primary cutaneous melanoma--biomarkers of potential utility?

Hum Pathol 2014 Oct 2;45(10):2094-100. Epub 2014 Jul 2.

Dermatopathology section, Department of Dermatology, Boston University School of Medicine, Boston, MA 02118. Electronic address:

View Article
October 2014
24 Reads
1 PubMed Central Citation(source)
2.77 Impact Factor
Top co-authors
Meera Mahalingam
Meera Mahalingam

Boston University School of Medicine

11
Shi Yang
Shi Yang

Renji Hospital

10
Brendon Mitchell
Brendon Mitchell

University of Florida College of Medicine

6
April Deng
April Deng

University of Maryland

5
Noah Frydenlund
Noah Frydenlund

Boston University School of Medicine

5
Rajendra Singh
Rajendra Singh

Institute of Tissue Regeneration Engineering (ITREN)

5
Asok Biswas
Asok Biswas

Western General Hospital

4
Ron Yaar
Ron Yaar

Boston University School of Medicine

4
Mai P Hoang
Mai P Hoang

Massachusetts General Hospital

3